Literature DB >> 23619359

Autoimmunity risk alleles: hotspots in B cell regulatory signaling pathways.

John C Cambier1.   

Abstract

Autoimmunity is the consequence of the combination of genetic predisposition and environmental effects, such as infection, injury, and constitution of the gut microbiome. In this edition of the JCI, Dai et al. describe the use of knockin technology to test the mechanism of action of a polymorphism in the protein tyrosine phosphatase nonreceptor 22 (PTPN22) (LYP) that is associated with susceptibility to multiple autoimmune diseases. The function of this allele, and that of a disproportionate number of autoimmune disease risk alleles, suggests that inhibitory signaling pathways that maintain B lymphocyte immune tolerance may represent an Achilles' heel in the prevention of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23619359      PMCID: PMC3635745          DOI: 10.1172/JCI69289

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

Review 1.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification.

Authors:  M Fujimoto; Y Fujimoto; J C Poe; P J Jansen; C A Lowell; A L DeFranco; T F Tedder
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

3.  Interaction of TAPP adapter proteins with phosphatidylinositol (3,4)-bisphosphate regulates B-cell activation and autoantibody production.

Authors:  Ivan Landego; Nipun Jayachandran; Stephan Wullschleger; Ting-ting Zhang; Ian W Gibson; Angela Miller; Dario R Alessi; Aaron J Marshall
Journal:  Eur J Immunol       Date:  2012-08-08       Impact factor: 5.532

4.  BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor.

Authors:  Kazumasa Yokoyama; I-hsin Su Ih; Tohru Tezuka; Tomoharu Yasuda; Katsuhiko Mikoshiba; Alexander Tarakhovsky; Tadashi Yamamoto
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

5.  Transcriptional effects of a lupus-associated polymorphism in the 5' untranslated region (UTR) of human complement receptor 2 (CR2/CD21).

Authors:  Mark N Cruickshank; Mahdad Karimi; Rhonda L Mason; Emily Fenwick; Tim Mercer; Betty P Tsao; Susan A Boackle; Daniela Ulgiati
Journal:  Mol Immunol       Date:  2012-06-04       Impact factor: 4.407

6.  B-cell kinase lyn deficiency in patients with systemic lupus erythematosus.

Authors:  S N Liossis; E E Solomou; M A Dimopoulos; P Panayiotidis; M M Mavrikakis; P P Sfikakis
Journal:  J Investig Med       Date:  2001-03       Impact factor: 2.895

7.  A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models.

Authors:  Xuezhi Dai; Richard G James; Tania Habib; Swati Singh; Shaun Jackson; Socheath Khim; Randall T Moon; Denny Liggitt; Alejandro Wolf-Yadlin; Jane H Buckner; David J Rawlings
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

8.  A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.

Authors:  Nunzio Bottini; Lucia Musumeci; Andres Alonso; Souad Rahmouni; Konstantina Nika; Masoud Rostamkhani; James MacMurray; Gian Franco Meloni; Paola Lucarelli; Maurizio Pellecchia; George S Eisenbarth; David Comings; Tomas Mustelin
Journal:  Nat Genet       Date:  2004-03-07       Impact factor: 38.330

Review 9.  Positive and negative roles of the tyrosine kinase Lyn in B cell function.

Authors:  A L DeFranco; V W Chan; C A Lowell
Journal:  Semin Immunol       Date:  1998-08       Impact factor: 11.130

10.  CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation.

Authors:  Nataly Manjarrez-Orduño; Emiliano Marasco; Sharon A Chung; Matthew S Katz; Jenna F Kiridly; Kim R Simpfendorfer; Jan Freudenberg; David H Ballard; Emil Nashi; Thomas J Hopkins; Deborah S Cunninghame Graham; Annette T Lee; Marieke J H Coenen; Barbara Franke; Dorine W Swinkels; Robert R Graham; Robert P Kimberly; Patrick M Gaffney; Timothy J Vyse; Timothy W Behrens; Lindsey A Criswell; Betty Diamond; Peter K Gregersen
Journal:  Nat Genet       Date:  2012-10-07       Impact factor: 38.330

View more
  22 in total

1.  Low level exposure to inorganic mercury interferes with B cell receptor signaling in transitional type 1 B cells.

Authors:  R Gill; M J McCabe; A J Rosenspire
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-28       Impact factor: 4.219

Review 2.  PTPN22: the archetypal non-HLA autoimmunity gene.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

Review 3.  Rationale for B cell targeting in SLE.

Authors:  Iñaki Sanz
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

4.  Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses.

Authors:  Xinrui Li; Jianming Wu; Travis Ptacek; David T Redden; Elizabeth E Brown; Graciela S Alarcón; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Richard A Kaslow; Robert P Kimberly; Jeffrey C Edberg
Journal:  Sci Transl Med       Date:  2013-12-18       Impact factor: 17.956

Review 5.  Regulation of autoimmune and anti-tumour T-cell responses by PTPN22.

Authors:  Rebecca J Brownlie; Rose Zamoyska; Robert J Salmond
Journal:  Immunology       Date:  2018-04-16       Impact factor: 7.397

Review 6.  B cells in type 1 diabetes mellitus and diabetic kidney disease.

Authors:  Mia J Smith; Kimber M Simmons; John C Cambier
Journal:  Nat Rev Nephrol       Date:  2017-10-17       Impact factor: 28.314

7.  A Precision B Cell-Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation.

Authors:  S Elizabeth Franks; Andrew Getahun; John C Cambier
Journal:  J Immunol       Date:  2019-05-10       Impact factor: 5.422

8.  B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens.

Authors:  Janie Akerlund; Andrew Getahun; John C Cambier
Journal:  J Autoimmun       Date:  2015-07-04       Impact factor: 7.094

Review 9.  Association between BLK polymorphisms and susceptibility to SLE : A meta-analysis.

Authors:  G G Song; Y H Lee
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

10.  The Role of Leukocyte-Associated Ig-like Receptor-1 in Suppressing Collagen-Induced Arthritis.

Authors:  Seunghyun Kim; Ellis R Easterling; Lauren C Price; Savannah L Smith; John E Coligan; Jeoung-Eun Park; David D Brand; Edward F Rosloniec; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  J Immunol       Date:  2017-09-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.